Quality of Life in Hemophilia by Clinical Scoring System (FISH)Score

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-28

Study Completion Date

2020-10-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To asses quality of life in patients with hemophilia clinically.-

-To avoid or minimize structural damage to goints and muscles by making patients aware of importance of rehabilitation

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Proprioceptive and Functional Characteristics in Patients With Hemophilia

NCT02165592

Hemophilia

UNKNOWN

Multiple Myeloma Prognostic Indices

NCT06095752

Multiple Myeloma Hematologic Diseases

COMPLETED

Validation of Questionnaires HAL and HEP

NCT02512211

Haemophilia

UNKNOWN

Scoring System of Structural Damage for the Hip in Juvenile Idiopathic Arthritis

NCT05206968

Juvenile Idiopathic Arthritis Hip

UNKNOWN

YEARS Score vs CTPA in Pulmonary Embolism

NCT06067308

Pulmonary Embolism

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hemophilia is a blood-clotting disorder caused by a deficiency in factor VIII (FVIII) or factor IX (FIX), which manifests itself through bleeding in the muscles and joints \[1\].

There are three categories, depending on the percentage of the blood-clotting factor: severe hemophilia (\<1% FVIII/IX), characterised by spontaneous bleeding; moderate hemophilia (1-5% FVIII/FIX), with bleeding from slight injuries; and mild hemophilia (\>5-40% FVIII/FIX) with bleeding during surgical procedures or from severe injuries(2).(3) Hemophilia C (a deficiency of Factor XI) is encountered, but its effect on clotting is far less pronounced than A or B Hemophilic arthropathy of the ankle causes pain and deterioration in gait, causing disability. Although some physiotherapy modalities are effective in the management of acute bleeding, the results are unknown in chronic arthropathy Due to the progression of hemophilic arthropathy and the resulting deterioration of the joint, deformities such as the estriction of motion (4). Physiotherapy through the RICE method (Rest, Ice, Compression, and Elevation) has been described for the improvement of acute joint injuries (5)as well as in the management of hemarthrosis in patients with hemophilia (6) Treatment of the ankle with physical therapy is complicated because it involves a small joint surface that bears significant ranges of body weight and the joint limitation alters biomechanical movement during walking(7) Prevention of musculoskeletal morbidity is an important objective in the treatment of hemophilia. Efficacy of such therapy has classically been measured by quantifying the extent of arthropathy using a joint scoring (8)(9)

Design of the Functional Independence Score in Hemophilia

Patients with hemophilia and their therapists were asked to list activities that could be affected by hemophilia. These were categorized according to the International Classification of Functioning, Disability and Health (ICF) (10)Activities that were considered unsafe to perform were excluded from the assessment. Other activities such as the use of transport, education and employment - that could not be assessed objectively in the clinic were also excluded. We finally included seven activities under three categories - self-care, transfers and locomotion (Table 1). Each activity was graded from 1 to 4 according to the amount of assistance required to perform the activity. Each activity and level of independence was clearly defined to reduce interobserver variation.core from 1 to 4 in each area:

1. = the subject is unable to perform the activity, or needs complete assistance to perform the activity;
2. = the subject needs partial assistance/aids/modified (9) (10) instruments/modified environment to perform the activity;
3. = the subject is able to perform the activity without aids or assistance, but with slight discomfort. He is unable to perform the activity like his healthy peers 11 4= the subject is able to perform the activity without any difficulty like other healthy pears

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemophilia Arthropathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* congenital Hemophilia A and B patients more than 18 years old

Exclusion Criteria

* All hemophilia patient less than 18 years old
* Patients with other bleeding disorders
* Patients with other comorbidities that can affect joint function as collagen disease
* Patients on steroids or non-steroidal analgesics

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No